MET fusions have been identified in several tumour types including gastric cancer, melanoma, thyroid carcinoma, papillary renal cell carcinoma (RCC), lung adenocarcinoma, hepatocellular carcinoma, glioma, colorectal cancer and sarcoma. The gene discussed is MET; the disease is renal cell carcinoma.